<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药物简讯 | wechat-feeds</title><link>http://MzI4OTIzMzcwMw.favicon.privacyhide.com/favicon.ico</link><description>【国内外药讯，医药市场，医药数据分享】</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 30 May 2021 07:33:50 +0800</pubDate><image><url>http://MzI4OTIzMzcwMw.favicon.privacyhide.com/favicon.ico</url><title>药物简讯 | wechat-feeds</title><link>http://MzI4OTIzMzcwMw.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>沃森、清华等联合开发的重组新冠疫苗获批临床</title><link>https://mp.weixin.qq.com/s/PUuAMwhXA6zXWDzyiTdtyg</link><description></description><content:encoded><![CDATA[沃森、清华等联合开发的重组新冠疫苗获批临床]]></content:encoded><pubDate>Sun, 30 May 2021 06:22:03 +0800</pubDate></item><item><title>亿一生物F-627上市申请获得FDA正式受理，有望明年获批上市</title><link>https://mp.weixin.qq.com/s/cERXIwoGFTujlW4lXWygfg</link><description></description><content:encoded><![CDATA[亿一生物F-627上市申请获得FDA正式受理，有望明年获批上市]]></content:encoded><pubDate>Sun, 30 May 2021 06:22:03 +0800</pubDate></item><item><title>博锐生物3款1类创新型生物制品临床试验申请先后获受理</title><link>https://mp.weixin.qq.com/s/SeXP1WDadp7j4obmFaqbYw</link><description></description><content:encoded><![CDATA[博锐生物3款1类创新型生物制品临床试验申请先后获受理]]></content:encoded><pubDate>Fri, 28 May 2021 16:09:01 +0800</pubDate></item><item><title>加科思KRAS G12C抑制剂IND中国获批 将启动中美多中心临床</title><link>https://mp.weixin.qq.com/s/HJzsY4KT9L8uiePPmsDXhw</link><description></description><content:encoded><![CDATA[加科思KRAS G12C抑制剂IND中国获批 将启动中美多中心临床]]></content:encoded><pubDate>Fri, 28 May 2021 16:09:01 +0800</pubDate></item><item><title>估值近40亿元！亚虹提交科创板IPO申请，拟募资20.7亿元</title><link>https://mp.weixin.qq.com/s/gc_VPC6PYpgFQE6W2YycqA</link><description></description><content:encoded><![CDATA[估值近40亿元！亚虹提交科创板IPO申请，拟募资20.7亿元]]></content:encoded><pubDate>Thu, 27 May 2021 12:34:42 +0800</pubDate></item><item><title>传奇生物BCMA CAR-T有望年底获FDA批准上市</title><link>https://mp.weixin.qq.com/s/7OAAlL5jNyQ3ILF66bxehw</link><description></description><content:encoded><![CDATA[传奇生物BCMA CAR-T有望年底获FDA批准上市]]></content:encoded><pubDate>Thu, 27 May 2021 12:34:42 +0800</pubDate></item><item><title>新冠疫苗如此赚钱？这家企业3个月净利润近100亿元</title><link>https://mp.weixin.qq.com/s/RS1hj6GDaBMplEvmVO1RxQ</link><description></description><content:encoded><![CDATA[新冠疫苗如此赚钱？这家企业3个月净利润近100亿元]]></content:encoded><pubDate>Tue, 25 May 2021 16:15:30 +0800</pubDate></item><item><title>越热门，新药走出来概览越大</title><link>https://mp.weixin.qq.com/s/0ZD1z1tZUhgAaGtkVoiAfA</link><description></description><content:encoded><![CDATA[越热门，新药走出来概览越大]]></content:encoded><pubDate>Sun, 23 May 2021 12:44:26 +0800</pubDate></item><item><title>全球同热AI:药物研发领域人工智能应用与创新发展策略探讨</title><link>https://mp.weixin.qq.com/s/VC0lufYLyVoyweDNYo2bew</link><description></description><content:encoded><![CDATA[全球同热AI:药物研发领域人工智能应用与创新发展策略探讨]]></content:encoded><pubDate>Sun, 23 May 2021 12:44:26 +0800</pubDate></item><item><title>重磅！药明康德10亿元参与发起设立100亿元药明汇英一期基金</title><link>https://mp.weixin.qq.com/s/0Vodtl2LIkupI0QRNGo3AA</link><description></description><content:encoded><![CDATA[重磅！药明康德10亿元参与发起设立100亿元药明汇英一期基金]]></content:encoded><pubDate>Fri, 21 May 2021 15:18:27 +0800</pubDate></item><item><title>石药/上海药物所合作开发BTK抑制剂获批临床</title><link>https://mp.weixin.qq.com/s/JAvxbRxXWpXXucNtcxiS4w</link><description></description><content:encoded><![CDATA[石药/上海药物所合作开发BTK抑制剂获批临床]]></content:encoded><pubDate>Thu, 20 May 2021 17:27:49 +0800</pubDate></item><item><title>三生国健投资企业Numab Therapeutics完成1.1亿美元C轮融资</title><link>https://mp.weixin.qq.com/s/zjmQCbDkEoyBdWT48lbd_A</link><description></description><content:encoded><![CDATA[三生国健投资企业Numab Therapeutics完成1.1亿美元C轮融资]]></content:encoded><pubDate>Thu, 20 May 2021 17:27:49 +0800</pubDate></item><item><title>估值25亿元！启德医药完成5亿元C轮融资， 三生国建出资1000万元！</title><link>https://mp.weixin.qq.com/s/cR6sVV-GUaFXYr3M8irFDA</link><description></description><content:encoded><![CDATA[估值25亿元！启德医药完成5亿元C轮融资， 三生国建出资1000万元！]]></content:encoded><pubDate>Wed, 19 May 2021 16:56:47 +0800</pubDate></item><item><title>重磅！信达提交信迪利单抗FDA上市申请！</title><link>https://mp.weixin.qq.com/s/CCevpvx-KVWa7HbCeP2QNg</link><description></description><content:encoded><![CDATA[重磅！信达提交信迪利单抗FDA上市申请！]]></content:encoded><pubDate>Tue, 18 May 2021 12:31:34 +0800</pubDate></item><item><title>又一家疫苗企业获超11亿元增资！</title><link>https://mp.weixin.qq.com/s/nk3UPMuh6wpiZkWa-7oOvw</link><description></description><content:encoded><![CDATA[又一家疫苗企业获超11亿元增资！]]></content:encoded><pubDate>Tue, 18 May 2021 12:31:34 +0800</pubDate></item><item><title>重磅！迈瑞超40亿元海外收购，展现国际化能力</title><link>https://mp.weixin.qq.com/s/Fo1Rs8WX5SzNcbPmY7Fx2A</link><description></description><content:encoded><![CDATA[重磅！迈瑞超40亿元海外收购，展现国际化能力]]></content:encoded><pubDate>Mon, 17 May 2021 08:08:31 +0800</pubDate></item><item><title>重磅！百济神州PARP抑制剂价格披露！</title><link>https://mp.weixin.qq.com/s/A-E8l-xKpAxvPWtFwQcfOg</link><description></description><content:encoded><![CDATA[重磅！百济神州PARP抑制剂价格披露！]]></content:encoded><pubDate>Mon, 17 May 2021 08:08:31 +0800</pubDate></item></channel></rss>